3//SEC Filing
Sofinnova Venture Partners IX, L.P. 3
Accession 0000899243-19-026791
CIK 0001563577other
Filed
Nov 5, 7:00 PM ET
Accepted
Nov 6, 5:22 PM ET
Size
16.1 KB
Accession
0000899243-19-026791
Insider Transaction Report
Form 3
Sofinnova Venture Partners IX, L.P.
10% Owner
Holdings
Series B-2 Preferred Stock
→ Common Stock (1,797,843 underlying)Series C Preferred Stock
→ Common Stock (535,869 underlying)
Sofinnova Management IX, L.L.C.
10% Owner
Holdings
Series B-2 Preferred Stock
→ Common Stock (1,797,843 underlying)Series C Preferred Stock
→ Common Stock (535,869 underlying)
POWELL MICHAEL
Director10% Owner
Holdings
Series B-2 Preferred Stock
→ Common Stock (1,797,843 underlying)Series C Preferred Stock
→ Common Stock (535,869 underlying)
HEALY JAMES
10% Owner
Holdings
Series B-2 Preferred Stock
→ Common Stock (1,797,843 underlying)Series C Preferred Stock
→ Common Stock (535,869 underlying)
Mehra Anand
10% Owner
Holdings
Series B-2 Preferred Stock
→ Common Stock (1,797,843 underlying)Series C Preferred Stock
→ Common Stock (535,869 underlying)
Footnotes (2)
- [F1]The shares reported herein are held of record by Sofinnova Venture Partners IX, L.P. ("SVP IX"). Dr. Michael F. Powell, Dr. James Healy and Dr. Anand Mehra are the managing members of Sofinnova Management IX, L.L.C., the general partner of SVP IX, and as such, may be deemed to share voting and investment power with respect to such shares. Each of the reporting persons disclaims beneficial ownership of such securities, except to the extent of such person's pecuniary interest therein.
- [F2]Each share of the Issuer's preferred stock is convertible into shares of the Issuer's common stock on a 0.197763-for-one basis at the holder's election and has no expiration date. The preferred stock will automatically convert into common stock upon the closing of the Issuer's initial public offering.
Issuer
Galera Therapeutics, Inc.
CIK 0001563577
Entity typeother
IncorporatedDE
Related Parties
1- filerCIK 0001612133
Filing Metadata
- Form type
- 3
- Filed
- Nov 5, 7:00 PM ET
- Accepted
- Nov 6, 5:22 PM ET
- Size
- 16.1 KB